Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AIM Immunotech, Amerimmune, Ampio, Astrazeneca, Bioage Labs, Biophytis, Curevac, Edesa, Eisai, Glaxosmithkline, Harbour Biomed, Histogen, Immutep, Incyte, Medicago, Merck, Moderna, Neurorx, Noxopharm, Reithera, Sanford Burnham Prebys Medical Discovery Institute, University of Hong Kong.